Clinical Utility and Reimbursement of Next-Generation Sequencing-Based Testing for Myeloid Malignancies

Next-generation sequencing is becoming increasingly important for the diagnosis, risk stratification, and management of patients with established or suspected myeloid malignancies. These tests are being incorporated into clinical practice guidelines and many genetic alterations now constitute diseas...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of molecular diagnostics : JMD 2024-01, Vol.26 (1), p.5-16
Hauptverfasser:	Soderquist, Craig R, Freeman, Christopher, Lin, Wen-Hsuan, Leeman-Neill, Rebecca J, Gu, Yue, Carter, Melissa C, Stutzel, Kate C, Sigcha, Evelyn, Alobeid, Bachir, Fernandes, Helen, Bhagat, Govind, Mansukhani, Mahesh M, Hsiao, Susan J
Format:	Artikel
Sprache:	eng
Schlagworte:	High-Throughput Nucleotide Sequencing - methods Humans Mutation Myeloproliferative Disorders - diagnosis Myeloproliferative Disorders - genetics Neoplasms
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!